Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SUBODH K BHUCHAR

Allopathic & Osteopathic Physicians Family Medicine

NPI
1629082417
CMS profile
210092
Location
SUGAR LAND, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$1,138.61

56 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,138.61 56

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 56 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SUBODH K BHUCHAR

NPI 1629082417 · CMS profile ID 210092

Allopathic & Osteopathic Physicians / Family Medicine

SUGAR LAND, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 56 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1629082417?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SUBODH K BHUCHAR, NPI 1629082417, CMS profile ID 210092. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 56 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1629082417?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). SUBODH K BHUCHAR, NPI 1629082417, CMS profile ID 210092. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 56 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1629082417?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
SUBODH K BHUCHAR, NPI 1629082417, CMS profile ID 210092, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 56 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1629082417?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

56 matching records · $1,138.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 56 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 56.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $11.6912/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227177857 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.0912/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225467459 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.0812/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222991494 CMS
Corcept Therapeutics $30.0111/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214162724 CMS
Amgen Inc. $18.4211/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228644747 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.3511/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222991492 CMS
ABBVIE INC. $19.2611/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201516362 CMS
Corcept Therapeutics $24.8211/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214162732 CMS
GlaxoSmithKline, LLC. $25.7911/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191523430 CMS
Amgen Inc. $20.8310/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228644739 CMS
ABBVIE INC. $18.1410/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201516360 CMS
Esperion Therapeutics, Inc. $15.3210/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243952831 CMS
Lilly USA, LLC $20.4210/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186869501 CMS
Corcept Therapeutics $21.8509/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214162692 CMS
Dexcom, Inc. $23.3009/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250530620 CMS
GlaxoSmithKline, LLC. $24.7109/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190365520 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.8609/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222991490 CMS
Novo Nordisk Inc $13.1409/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188145707 CMS
Novo Nordisk Inc $8.8709/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188490422 CMS
Astellas Pharma US Inc $19.5509/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238659314 CMS
Amgen Inc. $20.1408/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228644743 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.1508/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225467457 CMS
AstraZeneca Pharmaceuticals LP $21.4708/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1215342324 CMS
Currax Pharmaceuticals LLC $13.9808/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242707994 CMS
Corcept Therapeutics $23.8208/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214162638 CMS
ARS Pharmaceuticals Operations, Inc. $21.3608/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245868289 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.3008/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222991488 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.1507/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232009091 CMS
Novo Nordisk Inc $16.2507/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188274528 CMS
ABBVIE INC. $17.2707/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201516358 CMS
ARS Pharmaceuticals Operations, Inc. $29.9307/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245868287 CMS
AstraZeneca Pharmaceuticals LP $15.6707/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214799958 CMS
Amgen Inc. $22.9006/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228644749 CMS
Lilly USA, LLC $21.5806/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186926844 CMS
Novo Nordisk Inc $21.2606/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188859798 CMS
PFIZER INC. $19.1105/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229050492 CMS
Novo Nordisk Inc $20.4805/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188243540 CMS
Novo Nordisk Inc $33.7504/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188328720 CMS
Dexcom, Inc. $24.8404/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250530615 CMS
Amgen Inc. $19.5304/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228644745 CMS
Novo Nordisk Inc $4.9804/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188193280 CMS
Novo Nordisk Inc $27.6604/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188847901 CMS
GlaxoSmithKline, LLC. $22.4404/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191237720 CMS
Novo Nordisk Inc $24.2604/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188719090 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.3803/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225467455 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.6503/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232009088 CMS
Exact Sciences Corporation $19.9503/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235319890 CMS
Novo Nordisk Inc $13.3502/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188187144 CMS
Amgen Inc. $24.8502/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228644751 CMS
ABBVIE INC. $32.1302/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201516356 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $687.61 39
PY2020 $1,479.37 97
PY2021 $1,325.84 71
PY2022 $1,349.84 72
PY2023 $1,008.09 60
PY2024 $1,319.47 66
PY2025 $1,138.61 56

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $464,693.66 97
PY2024 Principal investigator $270,025.76 55
PY2023 Principal investigator $54,587.21 12
PY2022 Principal investigator $87,839.75 24
PY2021 Principal investigator $247,965.53 21
PY2020 Principal investigator $26,693.61 27
PY2019 Principal investigator $57,601.69 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Allergan, Inc. $1,260.00 12/31/2020 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 721317535
Principal investigator 1 AstraZeneca Pharmaceuticals LP $965.37 12/31/2020 Non-covered Recipient Entity
Pioneer Research Solutions Inc
A Randomized Double-Blind Parallel Group Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of PT001 to Placebo and Open-label Spiriva Respimat in Subjects With Persistent Asthma No dispute reported 06/30/2026 736743889
Principal investigator 1 Allergan, Inc. $86.00 12/22/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721313809
Principal investigator 1 Allergan, Inc. $315.00 12/03/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721310405
Principal investigator 1 Allergan, Inc. $315.00 12/03/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721310611
Principal investigator 1 Allergan, Inc. $315.00 11/05/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721306597
Principal investigator 1 Allergan, Inc. $371.00 11/05/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721306727
Principal investigator 1 Allergan, Inc. $700.00 10/08/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721301815
Principal investigator 1 Allergan, Inc. $1,805.00 09/16/2020 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 721297943
Principal investigator 1 Allergan, Inc. $86.00 09/15/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721297229
Principal investigator 1 Allergan, Inc. $86.00 09/03/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721294947
Principal investigator 1 Allergan, Inc. $86.00 08/27/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721293685
Principal investigator 1 Allergan, Inc. $86.00 07/30/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721287723
Principal investigator 1 Allergan, Inc. $700.00 07/30/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721287907
Principal investigator 1 Allergan, Inc. $700.00 05/05/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721273709
Principal investigator 1 Roche Products Limited $1,500.00 05/05/2020 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
PH3 RANDOMIZED MULTICENTER DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF OMALIZUMAB FOR NASAL POLYPS No dispute reported 06/30/2026 743111193
Principal investigator 1 Genentech, Inc. $2,197.38 04/14/2020 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
PH IIB OF MSTT1041A IN SEVERE UNCONTROLLED ASTHMA No dispute reported 06/30/2026 743111205
Principal investigator 1 Allergan, Inc. $86.00 03/26/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721267139
Principal investigator 1 Allergan, Inc. $86.00 03/26/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721267473
Principal investigator 1 Allergan, Inc. $86.00 03/12/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721263377
Principal investigator 1 Allergan, Inc. $86.00 03/05/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721262167
Principal investigator 1 AstraZeneca Pharmaceuticals LP $4,431.86 02/20/2020 Non-covered Recipient Entity
Pioneer Research Solutions Inc
A Randomized Double-Blind Parallel Group Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of PT001 to Placebo and Open-label Spiriva Respimat in Subjects With Persistent Asthma No dispute reported 06/30/2026 736745321
Principal investigator 1 Allergan, Inc. $86.00 01/28/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721252275
Principal investigator 1 Allergan, Inc. $86.00 01/28/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721252783
Principal investigator 1 Allergan, Inc. $86.00 01/21/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721249091
Principal investigator 1 Allergan, Inc. $86.00 01/21/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 721249183
Principal investigator 1 Allergan, Inc. $10,000.00 01/21/2020 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 721249527